Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/26/2012 | CN102335178B Oral solid pharmaceutical composition and preparation method thereof |
12/26/2012 | CN102327271B Levamlodipine and hydrochlorothiazide medicinal composition and preparation method thereof |
12/26/2012 | CN102309751B Superoxide dismutase (SOD) composite capsule and preparation method thereof |
12/26/2012 | CN102274320B Externally-applied heat-reducing medicinal liquor and use thereof |
12/26/2012 | CN102274226B Pharmaceutical use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide |
12/26/2012 | CN102266541B Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
12/26/2012 | CN102266459B Chinese medicinal spray for eliminating trauma gall and preparation method |
12/26/2012 | CN102266331B Brand new medicinal composition containing levamlodipine and losartan potassium and preparation method thereof |
12/26/2012 | CN102266304B Preparation method of oxacillin film-coated tablets |
12/26/2012 | CN102258492B Neostigmine bromide slow release preparation and its preparation method |
12/26/2012 | CN102258471B Preparation and application of sulfonated calix [4] arene-based nano supramolecular vesicles |
12/26/2012 | CN102247524B Preparation method of ophiopogon japonicus (Thunb.) Ker-Gawl total steroidal saponin extract, and application thereof in antisenescence pharmacy |
12/26/2012 | CN102247500B External use medicinal ointment for treating anorectal diseases and preparation method thereof |
12/26/2012 | CN102234277B Amino-acid-modified 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acids, and synthesis method and application thereof |
12/26/2012 | CN102228493B Medicine for treating coronary heart disease |
12/26/2012 | CN102228448B Cefuroxime axetil tablet and direct all-powder compression method thereof |
12/26/2012 | CN102204957B Liquid medicine for external use for treating exogenous wind-cold type common cold of children |
12/26/2012 | CN102204921B Application of tetracycline derivative in preparing sensitizing drug for radiotherapy |
12/26/2012 | CN102188388B Diclofenac sodium sustained-release pellet preparation and preparation method thereof |
12/26/2012 | CN102178934B Preparation for increasing bone mineral density, preventing osteoarthrosis and enhancing immunity |
12/26/2012 | CN102178932B Preparation for relieving fatigue and enhancing immunity |
12/26/2012 | CN102160650B Food containing glycine and use thereof |
12/26/2012 | CN102138921B Application of phthalimide derivatives in preparation of anti-angiogenesis medicaments |
12/26/2012 | CN102127041B Sialic acid analog and application thereof in preparation of anti-influenza-virus medicaments |
12/26/2012 | CN102119927B Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof |
12/26/2012 | CN102119919B Preparation method of valnemulin oily injection |
12/26/2012 | CN102114400B Method for preparing sodium alginate-iron chlorophyllin sodium microcapsule |
12/26/2012 | CN102114018B Compound controlled-release tablet with effect of regulating blood lipid and preparation method thereof |
12/26/2012 | CN102100685B PTP1B inhibitor and synthetic method and application thereof |
12/26/2012 | CN102088976B Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist |
12/26/2012 | CN102080086B Human miR-133a antisense nucleic acid and application thereof |
12/26/2012 | CN102078302B Method for preparing berbamine chitosan-agar nano particles |
12/26/2012 | CN102060941B 6-deoxy alpha-amino acid derivative cyclodextrin, preparation and application thereof |
12/26/2012 | CN102050830B Cephalosporin derivative containing nitrogen-containing fused-heterocycle |
12/26/2012 | CN102040615B Pyrrolin naphthene base-containing cephalo antibiotic |
12/26/2012 | CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection |
12/26/2012 | CN102038675B Application of ampelopsin for preparing medicaments for treating acne abscess, ulcer fester and piles |
12/26/2012 | CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method |
12/26/2012 | CN102028952B Galactan sulfate 5-fluorouracil compound and preparation and application thereof |
12/26/2012 | CN102008739B Solid refreshment agent |
12/26/2012 | CN102008712B Trandolapril-containing compound preparation for curing hypertension |
12/26/2012 | CN102008711B Compound preparation containing enalapril for treating hypertension |
12/26/2012 | CN102008709B Moexipril-contained compound preparation for treating hypertension |
12/26/2012 | CN102008707B Quinapril-contained compound preparation for treating hypertension |
12/26/2012 | CN102000063B Application of E ring benzyloxy substituted silybin in preparing glycosidase inhibitors |
12/26/2012 | CN102000061B Medicinal application of nitrobenzoyl silybin in preparation of glycosidase inhibitor |
12/26/2012 | CN102000058B Application of B/E ring changed silybin in preparing glycosidase inhibitors |
12/26/2012 | CN102000056B Pharmaceutical application of B ring methoxy substituted silybin in preparing glycosidase inhibitors |
12/26/2012 | CN101970009B Nicorandil carriers with enhanced stability |
12/26/2012 | CN101953773B Lamivudine liposome solid preparation |
12/26/2012 | CN101942393B Huperzia serrata endophytic fungus shiraia sp. strain for producing huperzine A |
12/26/2012 | CN101941950B 2-substituted benzo-[d] oxazole-5-propionic acid compound and preparation method and applications thereof |
12/26/2012 | CN101939002B Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
12/26/2012 | CN101932564B Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
12/26/2012 | CN101914092B Azabicyclo alkane derivative and preparation method and application thereof in medicaments |
12/26/2012 | CN101906119B Novel method for preparing tenofovir |
12/26/2012 | CN101889982B Novel long-circulating liposome composition and preparation method thereof |
12/26/2012 | CN101883567B Therapeutic use of diaminophenothiazines |
12/26/2012 | CN101855214B Benzimidazole derivatives and their use as FXR agonists |
12/26/2012 | CN101844970B Dibenzocyclooctene lignin derivatives with bioactivity |
12/26/2012 | CN101837011B Medicinal composition for treating diabetes |
12/26/2012 | CN101830884B Macrolide as well as preparation method and antibacterial application thereof |
12/26/2012 | CN101829154B Preparation method of medicine composition for preventing and treating asthma |
12/26/2012 | CN101820874B Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
12/26/2012 | CN101815716B Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
12/26/2012 | CN101815516B An antiviral composition |
12/26/2012 | CN101804047B Antimicrobial and radioprotective compounds |
12/26/2012 | CN101781319B Cephalosporin derivative containing substitutive triazole |
12/26/2012 | CN101774922B 2,3-dyhydroxyl parabens compound as well as preparation and application thereof |
12/26/2012 | CN101772345B A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
12/26/2012 | CN101759531B Preparation technology for water-soluble resveratrol particle, and product and application thereof |
12/26/2012 | CN101730703B Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
12/26/2012 | CN101708293B Anti-parasite slow-release oral agent for veterinary |
12/26/2012 | CN101687858B 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase |
12/26/2012 | CN101677983B Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists |
12/26/2012 | CN101676267B N-4-(1-cyan cyclopentyl) phenyl-2-(4-picolyl) amidogen-3-pyridinecarboxamide salt |
12/26/2012 | CN101674817B Novel use of hydroxytyrosol |
12/26/2012 | CN101648923B Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
12/26/2012 | CN101633623B Method for extracting mulberry leaf gamma-aminobutyric acid and application thereof |
12/26/2012 | CN101626765B Transcription factor modulating compounds and methods of use thereof |
12/26/2012 | CN101590023B Clopidogrel hydrogen sulfate tablet and preparation method thereof |
12/26/2012 | CN101553214B Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
12/26/2012 | CN101530413B Combined medicament for treating headache |
12/26/2012 | CN101528207B Transdermal therapeutic system for administering the active substance buprenorphine |
12/26/2012 | CN101495630B Gene involved in immortalization of human cancer cell and use thereof |
12/26/2012 | CN101466678B Substituted 3-cyanopyridines as protein kinase inhibitors |
12/26/2012 | CN101454006B Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids |
12/26/2012 | CN101437799B p38 MAP kinase inhibitors |
12/26/2012 | CN101365439B Levodopa prodrug mesylate, compositions thereof, and uses thereof |
12/26/2012 | CN101313926B Transcription regulating and controlling article composition |
12/26/2012 | CN101312952B 四氢-环戊二烯并吡唑大麻素调节剂 Tetrahydro - cyclopenta pyrazole cannabinoid modulators |
12/26/2012 | CN101304978B Quinazoline derivatives as a multiplex inhibitor, pharmaceutical composition and uses thereof |
12/26/2012 | CN101302208B Compound inhibiting glutathion S-transferase activity, preparation and use thereof |
12/26/2012 | CN101258143B 苄基哌嗪衍生物及其医学用途 Benzyl piperazine derivatives and their medical use |
12/26/2012 | CN101128425B Dimeric IAP inhibitors |
12/26/2012 | CN101106914B Novel nutraceutical compositions |
12/26/2012 | CN101076521B Process for producing muscarine receptor antagonist and intermediate therefor |
12/26/2012 | CN101062916B Three-substituted 1H-pyrromonazole compound, preparation method, medicament composition and pharmacy use thereof |
12/26/2012 | CN101010085B Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
12/25/2012 | USRE43879 Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug |